Jesduvroq
Payments companies reported to CMS as associated with Jesduvroq. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Jesduvroq, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Jesduvroq
These are the largest totals companies reported as associated with Jesduvroq. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jay Wish | Indianapolis, IN | Nephrology (Internal Medicine) | $59,107.98 |
| Anjay Rastogi | Los Angeles, CA | Nephrology (Internal Medicine) | $38,183.07 |
| Arnold Silva | Meridian, ID | Nephrology (Internal Medicine) | $29,033.16 |
| Bruce Spinowitz | Bronx, NY | Nephrology (Internal Medicine) | $24,657.48 |
| Jessica Coleman | Beaufort, SC | Nephrology (Internal Medicine) | $22,195.14 |
| Yasir Qazi | Orange, CA | Nephrology (Internal Medicine) | $17,375.02 |
| Wayne Kotzker | Fort Lauderdale, FL | Nephrology (Internal Medicine) | $15,614.73 |
| Michael Germain | Springfield, MA | Nephrology (Internal Medicine) | $14,268.93 |
| Abdul Abdellatif | Webster, TX | Nephrology (Internal Medicine) | $13,506.58 |
| Jose Morfin | Sacramento, CA | Nephrology (Internal Medicine) | $12,226.67 |
Prescribed Jesduvroq?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.